LOCUS       NM_000059              11386 bp    mRNA    linear   PRI 09-APR-2017
DEFINITION  Homo sapiens BRCA2, DNA repair associated (BRCA2), mRNA.
ACCESSION   NM_000059
VERSION     NM_000059.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 11386)
  AUTHORS   Ma J, Yang J, Jian W, Wang X, Xiao D, Xia W, Xiong L and Ma D.
  TITLE     A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG
            mutation found in a Chinese woman with family history of breast
            cancer
  JOURNAL   J. Cancer Res. Clin. Oncol. 143 (4), 631-637 (2017)
   PUBMED   28058502
  REMARK    GeneRIF: BRCA2-truncated protein resulted from the frame shift
            mutation was found to lose two putative nuclear localization
            signals and a Rad51-binding motif in the extreme C-terminal region
            by bioinformatic prediction
REFERENCE   2  (bases 1 to 11386)
  AUTHORS   Lakhi NA and Mizejewski GJ.
  TITLE     Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and
            Breast Cancer Susceptibility
  JOURNAL   Fetal Pediatr Pathol 36 (1), 49-61 (2017)
   PUBMED   27690720
  REMARK    GeneRIF: soluble alpha-fetoprotein is a marker for Fanconi anemia;
            FANC proteins form multi-protein complexes with BRCA proteins and
            are involved in homologous DNA repair [review]
            Review article
REFERENCE   3  (bases 1 to 11386)
  AUTHORS   Cao J, Luo C, Yan R, Peng R, Wang K, Wang P, Ye H and Song C.
  TITLE     rs15869 at miRNA binding site in BRCA2 is associated with breast
            cancer susceptibility
  JOURNAL   Med. Oncol. 33 (12), 135 (2016)
   PUBMED   27807724
  REMARK    GeneRIF: Findings suggest that the miRNA-binding SNPs in
            BRCA1/BRCA2 and their interaction with reproductive factors might
            contribute to BC risk, and miR-627 might down-regulate BRCA2
            expression in MCF-7 and MDA-MB-231 cells.
REFERENCE   4  (bases 1 to 11386)
  AUTHORS   Martinez-Useros J and Garcia-Foncillas J.
  TITLE     The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and
            Prognosis Biomarker for Pancreatic Cancer
  JOURNAL   Biomed Res Int 2016, 1869304 (2016)
   PUBMED   28078281
  REMARK    GeneRIF: the present systematic review collects and analyses the
            role of BRCA2 alterations to be used in early diagnosis of an
            inherited syndrome associated with familiar cancer and as a
            prognostic and predictive biomarker for the management of
            pancreatic cancer patients.
            Review article
REFERENCE   5  (bases 1 to 11386)
  AUTHORS   Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM,
            Leach R, Naylor S, Joenje H and Grompe M.
  TITLE     Microcell mediated chromosome transfer maps the Fanconi anaemia
            group D gene to chromosome 3p
  JOURNAL   Nat. Genet. 11 (3), 341-343 (1995)
   PUBMED   7581463
REFERENCE   6  (bases 1 to 11386)
  AUTHORS   Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E,
            Weinstein CL, Bittner M, Meltzer PS, Trent JM et al.
  TITLE     Identification by representational difference analysis of a
            homozygous deletion in pancreatic carcinoma that lies within the
            BRCA2 region
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 92 (13), 5950-5954 (1995)
   PUBMED   7597059
REFERENCE   7  (bases 1 to 11386)
  AUTHORS   Mehta,P.A. and Tolar,J.
  TITLE     Fanconi Anemia
  JOURNAL   (in) Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean
            LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH and Stephens K
            (Eds.);
            GENEREVIEWS(R);
            (1993)
   PUBMED   20301575
REFERENCE   8  (bases 1 to 11386)
  AUTHORS   Dome,J.S. and Huff,V.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean
            LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH and Stephens K
            (Eds.);
            GENEREVIEWS(R);
            (1993)
   PUBMED   20301471
REFERENCE   9  (bases 1 to 11386)
  AUTHORS   Petrucelli,N., Daly,M.B. and Pal,T.
  TITLE     BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
  JOURNAL   (in) Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean
            LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH and Stephens K
            (Eds.);
            GENEREVIEWS(R);
            (1993)
   PUBMED   20301425
REFERENCE   10 (bases 1 to 11386)
  AUTHORS   Watson,C.G.
  TITLE     The life of a resolution--how ADA policy is made
  JOURNAL   J Conf Workshop, 14-23 (1975)
   PUBMED   1072445
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL445212.9, U43746.1 and
            AL137247.14.
            This sequence is a reference standard in the RefSeqGene project.

            Summary: Inherited mutations in BRCA1 and this gene, BRCA2, confer
            increased lifetime risk of developing breast or ovarian cancer.
            Both BRCA1 and BRCA2 are involved in maintenance of genome
            stability, specifically the homologous recombination pathway for
            double-strand DNA repair. The BRCA2 protein contains several copies
            of a 70 aa motif called the BRC motif, and these motifs mediate
            binding to the RAD51 recombinase which functions in DNA repair.
            BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2
            mutations generally exhibit loss of heterozygosity (LOH) of the
            wild-type allele. [provided by RefSeq, Dec 2008].

            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.

            ##Evidence-Data-START##
            Transcript exon combination :: U43746.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1965299, SAMEA1968968
                                           [ECO:0000348]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..11386
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q13.1"
     gene            1..11386
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /note="BRCA2, DNA repair associated"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
     misc_feature    219..221
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /note="upstream in-frame stop codon"
     CDS             228..10484
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /note="BRCA1/BRCA2-containing complex, subunit 2;
                     truncated breast cancer 2; breast cancer 2 tumor
                     suppressor; breast and ovarian cancer susceptibility gene,
                     early onset; Fanconi anemia group D1 protein; breast and
                     ovarian cancer susceptibility protein 2; breast cancer 2,
                     early onset; mutant BRCA2"
                     /codon_start=1
                     /product="breast cancer type 2 susceptibility protein"
                     /protein_id="NP_000050.2"
                     /db_xref="CCDS:CCDS9344.1"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
                     /translation="MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNS
                     EPAEESEHKNNNYEPNLFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFK
                     LDLGRNVPNSRHKSLRTVKTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVV
                     CGSLFHTPKFVKGRQTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASE
                     TVFPHDTTANVKSYFSNHDESLKKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKV
                     NSCKDHIGKSMPNVLEDEVYETVVDTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFH
                     EANADECEKSKNQVKEKYSFVSEVEPNDTDPLDSNVANQKPFESGSDKISKEVVPSLA
                     CEWSQLTLSGLNGAQMEKIPLLHISSCDQNISEKDLLDTENKRKKDFLTSENSLPRIS
                     SLPKSEKPLNEETVVNKRDEEQHLESHTDCILAVKQAISGTSPVASSFQGIKKSIFRI
                     RESPKETFNASFSGHMTDPNFKKETEASESGLEIHTVCSQKEDSLCPNLIDNGSWPAT
                     TTQNSVALKNAGLISTLKKKTNKFIYAIHDETSYKGKKIPKDQKSELINCSAQFEANA
                     FEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLTSSFGTILRKCSRNETCSNNTVI
                     SQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCENDPKSKKVSDIKEEVLAAACHP
                     VQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLSNLVMISRGKESYKMSDKL
                     KGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYMRVASPSRKVQFNQNTN
                     LRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNNLALGNTKELHETDL
                     TCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVKQHIKMTLGQDLK
                     SDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLSEHNIKKSKMF
                     FKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSDCKNSHITP
                     QMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKSTFEVPE
                     NQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDCNKSA
                     SGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISLSS
                     SKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENE
                     DNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNT
                     QIKEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNI
                     SVAKESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKES
                     VPVGTGNQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQG
                     TSEITSFSHQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETV
                     VPPKLLSDNLCRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSA
                     LAFYTSCSRKTSVSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAE
                     NDKNHLSEKQDTYLSNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKN
                     TSFSKVISNVKDANAYPQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPP
                     AFRIASGKIVCVSHETIKKVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDS
                     EDILHNSLDNDECSTHSHKVFADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDIC
                     KCSIGKLHKSVSSANTCGIFSTASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLF
                     KSNEHSDQLTREENTAIRTPEHLISQKGFSYNVVNSSAFSGFSTASGKQVSILESSLH
                     KVKGVLEEFDLIRTEHSLHYSPTSRQNVSKILPRVDKRNPEHCVNSEMEKTCSKEFKL
                     SNNLNVEGGSSENNHSIKVSPYLSQFQQDKQQLVLGTKVSLVENIHVLGKEQASPKNV
                     KMEIGKTETFSDVPVKTNIEVCSTYSKDSENYFETEAVEIAKAFMEDDELTDSKLPSH
                     ATHSLFTCPENEEMVLSNSRIGKRRGEPLILVGEPSIKRNLLNEFDRIIENQEKSLKA
                     SKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKERQEIQNPNFTAPGQEFLSKSHLYE
                     HLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTGRPTKVFVPPFKTKSHFHRVEQC
                     VRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKNNSNQAAAVTFTKCEEEPLDL
                     ITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPRISLKAAVGGQVPSACSHK
                     QLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQLADGGWLIPSNDGKAG
                     KEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPKEFANRCLSPERVLL
                     QLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANISETSSNKTSSAD
                     TQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVGSPDACTPLEA
                     PESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDVIIQRAYPI
                     QWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENTTKPYLP
                     SRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKKQAQI
                     QLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLLTE
                     GKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKF
                     LDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHM
                     LIAASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEA
                     ENKLMHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCM
                     AKRKSVSTPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSP
                     AAQKAFQPPRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQ
                     ALLSGSTGEKQFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNK
                     QDTITTKKYI"
     misc_feature    228..347
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Interaction with PALB2"
     misc_feature    435..437
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    1560..1562
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    1701..1703
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    2142..3227
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Interaction with NPM1.
                     {ECO:0000269|PubMed:21084279}"
     misc_feature    2490..2492
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:17525332};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    3231..3335
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: BRCA2 1"
     misc_feature    3861..3965
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: BRCA2 2"
     misc_feature    4239..5570
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Interaction with POLH.
                     {ECO:0000269|PubMed:24485656}"
     misc_feature    4455..5012
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Required for stimulation of POLH DNA
                     polymerization activity"
     misc_feature    5736..5840
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: BRCA2 6"
     misc_feature    6135..6137
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    6138..6242
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: BRCA2 7"
     misc_feature    6330..6332
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphothreonine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    6378..6482
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: BRCA2 8"
     misc_feature    6510..6512
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    7275..7862
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Interaction with FANCD2"
     misc_feature    7668..8723
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Interaction with SEM1.
                     {ECO:0000269|PubMed:10373512,
                     ECO:0000269|PubMed:16205630}"
     misc_feature    8271..8321
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.3);
                     Region: Nuclear export signal, masked by interaction with
                     SEM1. {ECO:0000269|PubMed:24013206}"
     misc_feature    10098..10100
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by CDK1 and CDK2.
                     {ECO:0000269|PubMed:15800615}; propagated from
                     UniProtKB/Swiss-Prot (P51587.3); phosphorylation site"
     misc_feature    10182..10184
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163};
                     propagated from UniProtKB/Swiss-Prot (P51587.3);
                     phosphorylation site"
     misc_feature    10386..10388
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphothreonine, by CHEK1 and CHEK2.
                     {ECO:0000269|PubMed:18317453}; propagated from
                     UniProtKB/Swiss-Prot (P51587.3); phosphorylation site"
BASE COUNT     4108 a   1987 c   2112 g   3179 t
ORIGIN
        1 gtggcgcgag cttctgaaac taggcggcag aggcggagcc gctgtggcac tgctgcgcct
       61 ctgctgcgcc tcgggtgtct tttgcggcgg tgggtcgccg ccgggagaag cgtgagggga
      121 cagatttgtg accggcgcgg tttttgtcag cttactccgg ccaaaaaaga actgcacctc
      181 tggagcggac ttatttacca agcattggag gaatatcgta ggtaaaaatg cctattggat
      241 ccaaagagag gccaacattt tttgaaattt ttaagacacg ctgcaacaaa gcagatttag
      301 gaccaataag tcttaattgg tttgaagaac tttcttcaga agctccaccc tataattctg
      361 aacctgcaga agaatctgaa cataaaaaca acaattacga accaaaccta tttaaaactc
      421 cacaaaggaa accatcttat aatcagctgg cttcaactcc aataatattc aaagagcaag
      481 ggctgactct gccgctgtac caatctcctg taaaagaatt agataaattc aaattagact
      541 taggaaggaa tgttcccaat agtagacata aaagtcttcg cacagtgaaa actaaaatgg
      601 atcaagcaga tgatgtttcc tgtccacttc taaattcttg tcttagtgaa agtcctgttg
      661 ttctacaatg tacacatgta acaccacaaa gagataagtc agtggtatgt gggagtttgt
      721 ttcatacacc aaagtttgtg aagggtcgtc agacaccaaa acatatttct gaaagtctag
      781 gagctgaggt ggatcctgat atgtcttggt caagttcttt agctacacca cccaccctta
      841 gttctactgt gctcatagtc agaaatgaag aagcatctga aactgtattt cctcatgata
      901 ctactgctaa tgtgaaaagc tatttttcca atcatgatga aagtctgaag aaaaatgata
      961 gatttatcgc ttctgtgaca gacagtgaaa acacaaatca aagagaagct gcaagtcatg
     1021 gatttggaaa aacatcaggg aattcattta aagtaaatag ctgcaaagac cacattggaa
     1081 agtcaatgcc aaatgtccta gaagatgaag tatatgaaac agttgtagat acctctgaag
     1141 aagatagttt ttcattatgt ttttctaaat gtagaacaaa aaatctacaa aaagtaagaa
     1201 ctagcaagac taggaaaaaa attttccatg aagcaaacgc tgatgaatgt gaaaaatcta
     1261 aaaaccaagt gaaagaaaaa tactcatttg tatctgaagt ggaaccaaat gatactgatc
     1321 cattagattc aaatgtagca aatcagaagc cctttgagag tggaagtgac aaaatctcca
     1381 aggaagttgt accgtctttg gcctgtgaat ggtctcaact aaccctttca ggtctaaatg
     1441 gagcccagat ggagaaaata cccctattgc atatttcttc atgtgaccaa aatatttcag
     1501 aaaaagacct attagacaca gagaacaaaa gaaagaaaga ttttcttact tcagagaatt
     1561 ctttgccacg tatttctagc ctaccaaaat cagagaagcc attaaatgag gaaacagtgg
     1621 taaataagag agatgaagag cagcatcttg aatctcatac agactgcatt cttgcagtaa
     1681 agcaggcaat atctggaact tctccagtgg cttcttcatt tcagggtatc aaaaagtcta
     1741 tattcagaat aagagaatca cctaaagaga ctttcaatgc aagtttttca ggtcatatga
     1801 ctgatccaaa ctttaaaaaa gaaactgaag cctctgaaag tggactggaa atacatactg
     1861 tttgctcaca gaaggaggac tccttatgtc caaatttaat tgataatgga agctggccag
     1921 ccaccaccac acagaattct gtagctttga agaatgcagg tttaatatcc actttgaaaa
     1981 agaaaacaaa taagtttatt tatgctatac atgatgaaac atcttataaa ggaaaaaaaa
     2041 taccgaaaga ccaaaaatca gaactaatta actgttcagc ccagtttgaa gcaaatgctt
     2101 ttgaagcacc acttacattt gcaaatgctg attcaggttt attgcattct tctgtgaaaa
     2161 gaagctgttc acagaatgat tctgaagaac caactttgtc cttaactagc tcttttggga
     2221 caattctgag gaaatgttct agaaatgaaa catgttctaa taatacagta atctctcagg
     2281 atcttgatta taaagaagca aaatgtaata aggaaaaact acagttattt attaccccag
     2341 aagctgattc tctgtcatgc ctgcaggaag gacagtgtga aaatgatcca aaaagcaaaa
     2401 aagtttcaga tataaaagaa gaggtcttgg ctgcagcatg tcacccagta caacattcaa
     2461 aagtggaata cagtgatact gactttcaat cccagaaaag tcttttatat gatcatgaaa
     2521 atgccagcac tcttatttta actcctactt ccaaggatgt tctgtcaaac ctagtcatga
     2581 tttctagagg caaagaatca tacaaaatgt cagacaagct caaaggtaac aattatgaat
     2641 ctgatgttga attaaccaaa aatattccca tggaaaagaa tcaagatgta tgtgctttaa
     2701 atgaaaatta taaaaacgtt gagctgttgc cacctgaaaa atacatgaga gtagcatcac
     2761 cttcaagaaa ggtacaattc aaccaaaaca caaatctaag agtaatccaa aaaaatcaag
     2821 aagaaactac ttcaatttca aaaataactg tcaatccaga ctctgaagaa cttttctcag
     2881 acaatgagaa taattttgtc ttccaagtag ctaatgaaag gaataatctt gctttaggaa
     2941 atactaagga acttcatgaa acagacttga cttgtgtaaa cgaacccatt ttcaagaact
     3001 ctaccatggt tttatatgga gacacaggtg ataaacaagc aacccaagtg tcaattaaaa
     3061 aagatttggt ttatgttctt gcagaggaga acaaaaatag tgtaaagcag catataaaaa
     3121 tgactctagg tcaagattta aaatcggaca tctccttgaa tatagataaa ataccagaaa
     3181 aaaataatga ttacatgaac aaatgggcag gactcttagg tccaatttca aatcacagtt
     3241 ttggaggtag cttcagaaca gcttcaaata aggaaatcaa gctctctgaa cataacatta
     3301 agaagagcaa aatgttcttc aaagatattg aagaacaata tcctactagt ttagcttgtg
     3361 ttgaaattgt aaataccttg gcattagata atcaaaagaa actgagcaag cctcagtcaa
     3421 ttaatactgt atctgcacat ttacagagta gtgtagttgt ttctgattgt aaaaatagtc
     3481 atataacccc tcagatgtta ttttccaagc aggattttaa ttcaaaccat aatttaacac
     3541 ctagccaaaa ggcagaaatt acagaacttt ctactatatt agaagaatca ggaagtcagt
     3601 ttgaatttac tcagtttaga aaaccaagct acatattgca gaagagtaca tttgaagtgc
     3661 ctgaaaacca gatgactatc ttaaagacca cttctgagga atgcagagat gctgatcttc
     3721 atgtcataat gaatgcccca tcgattggtc aggtagacag cagcaagcaa tttgaaggta
     3781 cagttgaaat taaacggaag tttgctggcc tgttgaaaaa tgactgtaac aaaagtgctt
     3841 ctggttattt aacagatgaa aatgaagtgg ggtttagggg cttttattct gctcatggca
     3901 caaaactgaa tgtttctact gaagctctgc aaaaagctgt gaaactgttt agtgatattg
     3961 agaatattag tgaggaaact tctgcagagg tacatccaat aagtttatct tcaagtaaat
     4021 gtcatgattc tgttgtttca atgtttaaga tagaaaatca taatgataaa actgtaagtg
     4081 aaaaaaataa taaatgccaa ctgatattac aaaataatat tgaaatgact actggcactt
     4141 ttgttgaaga aattactgaa aattacaaga gaaatactga aaatgaagat aacaaatata
     4201 ctgctgccag tagaaattct cataacttag aatttgatgg cagtgattca agtaaaaatg
     4261 atactgtttg tattcataaa gatgaaacgg acttgctatt tactgatcag cacaacatat
     4321 gtcttaaatt atctggccag tttatgaagg agggaaacac tcagattaaa gaagatttgt
     4381 cagatttaac ttttttggaa gttgcgaaag ctcaagaagc atgtcatggt aatacttcaa
     4441 ataaagaaca gttaactgct actaaaacgg agcaaaatat aaaagatttt gagacttctg
     4501 atacattttt tcagactgca agtgggaaaa atattagtgt cgccaaagag tcatttaata
     4561 aaattgtaaa tttctttgat cagaaaccag aagaattgca taacttttcc ttaaattctg
     4621 aattacattc tgacataaga aagaacaaaa tggacattct aagttatgag gaaacagaca
     4681 tagttaaaca caaaatactg aaagaaagtg tcccagttgg tactggaaat caactagtga
     4741 ccttccaggg acaacccgaa cgtgatgaaa agatcaaaga acctactcta ttgggttttc
     4801 atacagctag cgggaaaaaa gttaaaattg caaaggaatc tttggacaaa gtgaaaaacc
     4861 tttttgatga aaaagagcaa ggtactagtg aaatcaccag ttttagccat caatgggcaa
     4921 agaccctaaa gtacagagag gcctgtaaag accttgaatt agcatgtgag accattgaga
     4981 tcacagctgc cccaaagtgt aaagaaatgc agaattctct caataatgat aaaaaccttg
     5041 tttctattga gactgtggtg ccacctaagc tcttaagtga taatttatgt agacaaactg
     5101 aaaatctcaa aacatcaaaa agtatctttt tgaaagttaa agtacatgaa aatgtagaaa
     5161 aagaaacagc aaaaagtcct gcaacttgtt acacaaatca gtccccttat tcagtcattg
     5221 aaaattcagc cttagctttt tacacaagtt gtagtagaaa aacttctgtg agtcagactt
     5281 cattacttga agcaaaaaaa tggcttagag aaggaatatt tgatggtcaa ccagaaagaa
     5341 taaatactgc agattatgta ggaaattatt tgtatgaaaa taattcaaac agtactatag
     5401 ctgaaaatga caaaaatcat ctctccgaaa aacaagatac ttatttaagt aacagtagca
     5461 tgtctaacag ctattcctac cattctgatg aggtatataa tgattcagga tatctctcaa
     5521 aaaataaact tgattctggt attgagccag tattgaagaa tgttgaagat caaaaaaaca
     5581 ctagtttttc caaagtaata tccaatgtaa aagatgcaaa tgcataccca caaactgtaa
     5641 atgaagatat ttgcgttgag gaacttgtga ctagctcttc accctgcaaa aataaaaatg
     5701 cagccattaa attgtccata tctaatagta ataattttga ggtagggcca cctgcattta
     5761 ggatagccag tggtaaaatc gtttgtgttt cacatgaaac aattaaaaaa gtgaaagaca
     5821 tatttacaga cagtttcagt aaagtaatta aggaaaacaa cgagaataaa tcaaaaattt
     5881 gccaaacgaa aattatggca ggttgttacg aggcattgga tgattcagag gatattcttc
     5941 ataactctct agataatgat gaatgtagca cgcattcaca taaggttttt gctgacattc
     6001 agagtgaaga aattttacaa cataaccaaa atatgtctgg attggagaaa gtttctaaaa
     6061 tatcaccttg tgatgttagt ttggaaactt cagatatatg taaatgtagt atagggaagc
     6121 ttcataagtc agtctcatct gcaaatactt gtgggatttt tagcacagca agtggaaaat
     6181 ctgtccaggt atcagatgct tcattacaaa acgcaagaca agtgttttct gaaatagaag
     6241 atagtaccaa gcaagtcttt tccaaagtat tgtttaaaag taacgaacat tcagaccagc
     6301 tcacaagaga agaaaatact gctatacgta ctccagaaca tttaatatcc caaaaaggct
     6361 tttcatataa tgtggtaaat tcatctgctt tctctggatt tagtacagca agtggaaagc
     6421 aagtttccat tttagaaagt tccttacaca aagttaaggg agtgttagag gaatttgatt
     6481 taatcagaac tgagcatagt cttcactatt cacctacgtc tagacaaaat gtatcaaaaa
     6541 tacttcctcg tgttgataag agaaacccag agcactgtgt aaactcagaa atggaaaaaa
     6601 cctgcagtaa agaatttaaa ttatcaaata acttaaatgt tgaaggtggt tcttcagaaa
     6661 ataatcactc tattaaagtt tctccatatc tctctcaatt tcaacaagac aaacaacagt
     6721 tggtattagg aaccaaagtg tcacttgttg agaacattca tgttttggga aaagaacagg
     6781 cttcacctaa aaacgtaaaa atggaaattg gtaaaactga aactttttct gatgttcctg
     6841 tgaaaacaaa tatagaagtt tgttctactt actccaaaga ttcagaaaac tactttgaaa
     6901 cagaagcagt agaaattgct aaagctttta tggaagatga tgaactgaca gattctaaac
     6961 tgccaagtca tgccacacat tctcttttta catgtcccga aaatgaggaa atggttttgt
     7021 caaattcaag aattggaaaa agaagaggag agccccttat cttagtggga gaaccctcaa
     7081 tcaaaagaaa cttattaaat gaatttgaca ggataataga aaatcaagaa aaatccttaa
     7141 aggcttcaaa aagcactcca gatggcacaa taaaagatcg aagattgttt atgcatcatg
     7201 tttctttaga gccgattacc tgtgtaccct ttcgcacaac taaggaacgt caagagatac
     7261 agaatccaaa ttttaccgca cctggtcaag aatttctgtc taaatctcat ttgtatgaac
     7321 atctgacttt ggaaaaatct tcaagcaatt tagcagtttc aggacatcca ttttatcaag
     7381 tttctgctac aagaaatgaa aaaatgagac acttgattac tacaggcaga ccaaccaaag
     7441 tctttgttcc accttttaaa actaaatcac attttcacag agttgaacag tgtgttagga
     7501 atattaactt ggaggaaaac agacaaaagc aaaacattga tggacatggc tctgatgata
     7561 gtaaaaataa gattaatgac aatgagattc atcagtttaa caaaaacaac tccaatcaag
     7621 cagcagctgt aactttcaca aagtgtgaag aagaaccttt agatttaatt acaagtcttc
     7681 agaatgccag agatatacag gatatgcgaa ttaagaagaa acaaaggcaa cgcgtctttc
     7741 cacagccagg cagtctgtat cttgcaaaaa catccactct gcctcgaatc tctctgaaag
     7801 cagcagtagg aggccaagtt ccctctgcgt gttctcataa acagctgtat acgtatggcg
     7861 tttctaaaca ttgcataaaa attaacagca aaaatgcaga gtcttttcag tttcacactg
     7921 aagattattt tggtaaggaa agtttatgga ctggaaaagg aatacagttg gctgatggtg
     7981 gatggctcat accctccaat gatggaaagg ctggaaaaga agaattttat agggctctgt
     8041 gtgacactcc aggtgtggat ccaaagctta tttctagaat ttgggtttat aatcactata
     8101 gatggatcat atggaaactg gcagctatgg aatgtgcctt tcctaaggaa tttgctaata
     8161 gatgcctaag cccagaaagg gtgcttcttc aactaaaata cagatatgat acggaaattg
     8221 atagaagcag aagatcggct ataaaaaaga taatggaaag ggatgacaca gctgcaaaaa
     8281 cacttgttct ctgtgtttct gacataattt cattgagcgc aaatatatct gaaacttcta
     8341 gcaataaaac tagtagtgca gatacccaaa aagtggccat tattgaactt acagatgggt
     8401 ggtatgctgt taaggcccag ttagatcctc ccctcttagc tgtcttaaag aatggcagac
     8461 tgacagttgg tcagaagatt attcttcatg gagcagaact ggtgggctct cctgatgcct
     8521 gtacacctct tgaagcccca gaatctctta tgttaaagat ttctgctaac agtactcggc
     8581 ctgctcgctg gtataccaaa cttggattct ttcctgaccc tagacctttt cctctgccct
     8641 tatcatcgct tttcagtgat ggaggaaatg ttggttgtgt tgatgtaatt attcaaagag
     8701 cataccctat acagtggatg gagaagacat catctggatt atacatattt cgcaatgaaa
     8761 gagaggaaga aaaggaagca gcaaaatatg tggaggccca acaaaagaga ctagaagcct
     8821 tattcactaa aattcaggag gaatttgaag aacatgaaga aaacacaaca aaaccatatt
     8881 taccatcacg tgcactaaca agacagcaag ttcgtgcttt gcaagatggt gcagagcttt
     8941 atgaagcagt gaagaatgca gcagacccag cttaccttga gggttatttc agtgaagagc
     9001 agttaagagc cttgaataat cacaggcaaa tgttgaatga taagaaacaa gctcagatcc
     9061 agttggaaat taggaaggcc atggaatctg ctgaacaaaa ggaacaaggt ttatcaaggg
     9121 atgtcacaac cgtgtggaag ttgcgtattg taagctattc aaaaaaagaa aaagattcag
     9181 ttatactgag tatttggcgt ccatcatcag atttatattc tctgttaaca gaaggaaaga
     9241 gatacagaat ttatcatctt gcaacttcaa aatctaaaag taaatctgaa agagctaaca
     9301 tacagttagc agcgacaaaa aaaactcagt atcaacaact accggtttca gatgaaattt
     9361 tatttcagat ttaccagcca cgggagcccc ttcacttcag caaattttta gatccagact
     9421 ttcagccatc ttgttctgag gtggacctaa taggatttgt cgtttctgtt gtgaaaaaaa
     9481 caggacttgc ccctttcgtc tatttgtcag acgaatgtta caatttactg gcaataaagt
     9541 tttggataga ccttaatgag gacattatta agcctcatat gttaattgct gcaagcaacc
     9601 tccagtggcg accagaatcc aaatcaggcc ttcttacttt atttgctgga gatttttctg
     9661 tgttttctgc tagtccaaaa gagggccact ttcaagagac attcaacaaa atgaaaaata
     9721 ctgttgagaa tattgacata ctttgcaatg aagcagaaaa caagcttatg catatactgc
     9781 atgcaaatga tcccaagtgg tccaccccaa ctaaagactg tacttcaggg ccgtacactg
     9841 ctcaaatcat tcctggtaca ggaaacaagc ttctgatgtc ttctcctaat tgtgagatat
     9901 attatcaaag tcctttatca ctttgtatgg ccaaaaggaa gtctgtttcc acacctgtct
     9961 cagcccagat gacttcaaag tcttgtaaag gggagaaaga gattgatgac caaaagaact
    10021 gcaaaaagag aagagccttg gatttcttga gtagactgcc tttacctcca cctgttagtc
    10081 ccatttgtac atttgtttct ccggctgcac agaaggcatt tcagccacca aggagttgtg
    10141 gcaccaaata cgaaacaccc ataaagaaaa aagaactgaa ttctcctcag atgactccat
    10201 ttaaaaaatt caatgaaatt tctcttttgg aaagtaattc aatagctgac gaagaacttg
    10261 cattgataaa tacccaagct cttttgtctg gttcaacagg agaaaaacaa tttatatctg
    10321 tcagtgaatc cactaggact gctcccacca gttcagaaga ttatctcaga ctgaaacgac
    10381 gttgtactac atctctgatc aaagaacagg agagttccca ggccagtacg gaagaatgtg
    10441 agaaaaataa gcaggacaca attacaacta aaaaatatat ctaagcattt gcaaaggcga
    10501 caataaatta ttgacgctta acctttccag tttataagac tggaatataa tttcaaacca
    10561 cacattagta cttatgttgc acaatgagaa aagaaattag tttcaaattt acctcagcgt
    10621 ttgtgtatcg ggcaaaaatc gttttgcccg attccgtatt ggtatacttt tgcttcagtt
    10681 gcatatctta aaactaaatg taatttatta actaatcaag aaaaacatct ttggctgagc
    10741 tcggtggctc atgcctgtaa tcccaacact ttgagaagct gaggtgggag gagtgcttga
    10801 ggccaggagt tcaagaccag cctgggcaac atagggagac ccccatcttt acaaagaaaa
    10861 aaaaaagggg aaaagaaaat cttttaaatc tttggatttg atcactacaa gtattatttt
    10921 acaagtgaaa taaacatacc attttctttt agattgtgtc attaaatgga atgaggtctc
    10981 ttagtacagt tattttgatg cagataattc cttttagttt agctactatt ttaggggatt
    11041 ttttttagag gtaactcact atgaaatagt tctccttaat gcaaatatgt tggttctgct
    11101 atagttccat cctgttcaaa agtcaggatg aatatgaaga gtggtgtttc cttttgagca
    11161 attcttcatc cttaagtcag catgattata agaaaaatag aaccctcagt gtaactctaa
    11221 ttccttttta ctattccagt gtgatctctg aaattaaatt acttcaacta aaaattcaaa
    11281 tactttaaat cagaagattt catagttaat ttattttttt tttcaacaaa atggtcatcc
    11341 aaactcaaac ttgagaaaat atcttgcttt caaattggca ctgatt
//
